Dr. Dario Nicolas Kivelevitch, MD

Dr. Kivelevitch practices at U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas.

Dr. Kivelevitch's NPI, 1922485838, was assigned on April 29, 2015. Dr. Kivelevitch graduated from University of Buenos Aires in 2000. Dr. Kivelevitch holds Texas license R6810.

Dr. Kivelevitch's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza, at 1367 Dominion Plz, Tyler, TX 75703. The practice phone is (903) 534-6200.

Dr. Kivelevitch's primary practice is U.S. Dermatology Partners Tyler on Dominion Plaza in Tyler, Texas. Dr. Kivelevitch is also affiliated with Baylor University Medical Center. The medical group on file is U.S. Dermatology Partners. Dmand AI also links Dr. Kivelevitch to 1 more physician office and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kivelevitch practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Kivelevitch's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Kivelevitch is board certified in dermatology by the American Board of Dermatology. Dr. Kivelevitch is licensed in Texas.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Kivelevitch treats.

CMS data shows 1,140 Medicare services from Dr. Kivelevitch across 12 procedure codes in 2024, for 262 Medicare patients. Medicare paid $69,571 for them. Every service was in an office.

CMS counts 262 Medicare patients who saw Dr. Kivelevitch in 2024. The largest group is 65 to 74, with 124 patients. 75% of them have high cholesterol, and 68% have high blood pressure. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kivelevitch's median patient age at 66, with 50% women.

In 2024, Dr. Kivelevitch wrote 722 Medicare Part D claims for 225 patients. 84% of them were for generic drugs. CMS names the drug for 550 of them, across 17 drugs with 11 or more claims each, at $256,290 in total drug cost. In 2023, CMS named 595 claims across 18 drugs.

Dr. Kivelevitch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 327 procedures of removal of skin lesions by Dr. Kivelevitch, more than 83% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 43 papers to Dr. Kivelevitch, published from 2013 to 2025. 2017 was the busiest year, with 12. The most frequent topics are Psoriasis, Dermatologic Agents and Antibodies, Monoclonal. Dr. Kivelevitch has published most often in J Am Acad Dermatol. Dr. Kivelevitch's most frequent co-authors are Jillian H. Frieder, MD, Bobbak Mansouri, MD and Nehal N. Mehta, MD.

Dmand AI links Dr. Kivelevitch to 1 clinical trial. Conditions studied include Psoriasis and Skin Diseases, Papulosquamous.

CMS Open Payments shows 1,416 general payments to Dr. Kivelevitch from 41 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $117,564. It also lists 1 research payment totaling $4,375 in 2020.

Dr. Kivelevitch graduated from University of Buenos Aires in 2000.

Dr. Kivelevitch is in network with 22 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.